- Home
- C vs SYK Comparison
C vs SYK Comparison
Compare C & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- C
- SYK
- Stock Information
- Founded
- C 1812
- SYK 1941
- Country
- C United States
- SYK United States
- Employees
- C N/A
- SYK N/A
- Industry
- C Major Banks
- SYK Medical/Dental Instruments
- Sector
- C Finance
- SYK Health Care
- Exchange
- C Nasdaq
- SYK Nasdaq
- Market Cap
- C 132.9B
- SYK 139.3B
- IPO Year
- C N/A
- SYK N/A
- Fundamental
- Price
- C $71.63
- SYK $382.45
- Analyst Decision
- C Buy
- SYK Buy
- Analyst Count
- C 14
- SYK 19
- Target Price
- C $86.32
- SYK $424.28
- AVG Volume (30 Days)
- C 15.2M
- SYK 1.6M
- Earning Date
- C 04-15-2025
- SYK 05-01-2025
- Dividend Yield
- C 3.13%
- SYK 0.88%
- EPS Growth
- C 85.23
- SYK N/A
- EPS
- C 6.33
- SYK 7.40
- Revenue
- C $71,819,000,000.00
- SYK $23,218,000,000.00
- Revenue This Year
- C $19.71
- SYK $9.78
- Revenue Next Year
- C $3.21
- SYK $7.53
- P/E Ratio
- C $11.32
- SYK $51.69
- Revenue Growth
- C 3.12
- SYK 10.76
- 52 Week Low
- C $53.51
- SYK $314.93
- 52 Week High
- C $84.74
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- C 60.95
- SYK 61.98
- Support Level
- C $69.17
- SYK $363.08
- Resistance Level
- C $70.94
- SYK $383.99
- Average True Range (ATR)
- C 1.51
- SYK 8.72
- MACD
- C 0.81
- SYK 3.36
- Stochastic Oscillator
- C 94.07
- SYK 89.12
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.